Olaris Company
Olaris is on a mission to revolutionize how diseases are diagnosed and treated through the combination of metabolomics and machine learning
Founded Date:
2013-06-01
Last Funding Type:
Series B
Headquarters:
Framingham, Massachusetts, United States
Investors Number:
3.0
Technology:
Biopharma, Biotechnology, Health Care
Employee Number:
1-10
Industry:
Early Drug Development
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-09-23
Funding Status:
Early Stage Venture